{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:21:52Z","timestamp":1793830912714,"version":"4.6.1"},"reference-count":81,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T00:00:00Z","timestamp":1730246400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asian Journal of Surgery"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.asjsur.2024.10.155","type":"journal-article","created":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T07:03:24Z","timestamp":1731999804000},"page":"986-995","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Hyperthermic intraperitoneal chemotherapy: Ideal and reality"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1808-1174","authenticated-orcid":false,"given":"Fan-He","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2242-8334","authenticated-orcid":false,"given":"Yu-Qiang","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Cheng","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-Ran","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin-Po","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye-Bin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Hao","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Jia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.asjsur.2024.10.155_bib1","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3322\/caac.21277","article-title":"Looking up: recent advances in understanding and treating peritoneal carcinomatosis","volume":"65","author":"Lambert","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.asjsur.2024.10.155_bib2","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.21037\/jgo-20-46","article-title":"Hyperthermic intra-operative intraperitoneal chemotherapy as an adjuvant to pancreatic cancer resection","volume":"12","author":"Tentes","year":"2021","journal-title":"J\u00a0Gastrointest Oncol"},{"key":"10.1016\/j.asjsur.2024.10.155_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241512353","article-title":"The role of hyperthermic intraperitoneal chemotherapy in uterine cancer therapy","volume":"24","author":"Psilopatis","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.asjsur.2024.10.155_bib4","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.suc.2020.02.009","article-title":"Peritoneal cancers and hyperthermic intraperitoneal chemotherapy","volume":"100","author":"Pletcher","year":"2020","journal-title":"Surg Clin North Am"},{"key":"10.1016\/j.asjsur.2024.10.155_bib5","article-title":"Effects of neoadjuvant intraperitoneal\/systemic chemotherapy (bidirectional chemotherapy) for the treatment of patients with peritoneal metastasis from gastric cancer","author":"Yonemura","year":"2012","journal-title":"Int J Surg Oncol"},{"key":"10.1016\/j.asjsur.2024.10.155_bib6","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.asjsur.2024.10.155_bib7","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40880-019-0368-6","article-title":"Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?","volume":"39","author":"Feng","year":"2019","journal-title":"Cancer Commun"},{"key":"10.1016\/j.asjsur.2024.10.155_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/cells9081775","article-title":"The temperature-dependent effectiveness of platinum-based drugs mitomycin-C and 5-FU during hyperthermic intraperitoneal chemotherapy (HIPEC) in colorectal cancer cell lines","volume":"9","author":"Helderman","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.asjsur.2024.10.155_bib9","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1200\/JCO.18.01688","article-title":"Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastases (CYTO-CHIP study): a Propensity score analysis","volume":"37","author":"Bonnot","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.asjsur.2024.10.155_bib10","first-page":"256","article-title":"Clinical delivery system for intraperitoneal hyperthermic chemotherapy","volume":"40","author":"Spratt","year":"1980","journal-title":"Cancer Res"},{"key":"10.1016\/j.asjsur.2024.10.155_bib11","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1007\/s00464-020-07572-x","article-title":"Laparoscopic cytoreductive surgery and HIPEC: a comparative matched analysis","volume":"35","author":"Rodr\u00edguez-Ortiz","year":"2021","journal-title":"Surg Endosc"},{"key":"10.1016\/j.asjsur.2024.10.155_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15010279","article-title":"Laparoscopic cytoreduction combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in peritoneal surface malignancies (PSM): Italian PSM Oncoteam evidence and literature review","volume":"15","author":"Sommariva","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.asjsur.2024.10.155_bib13","doi-asserted-by":"crossref","first-page":"241","DOI":"10.21037\/jgo.2017.12.04","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in ovarian and gastrointestinal peritoneal carcinomatosis: results from a 7-year experience","volume":"9","author":"Montori","year":"2018","journal-title":"J\u00a0Gastrointest Oncol"},{"key":"10.1016\/j.asjsur.2024.10.155_bib14","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/annonc\/mdl428","article-title":"A\u00a0systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignancy peritoneal mesothelioma","volume":"18","author":"Yan","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1016\/j.asjsur.2024.10.155_bib15","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1040-8428(01)00179-2","article-title":"The cellular and molecular basis of hyperthermia","volume":"43","author":"Hildebrandt","year":"2002","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.asjsur.2024.10.155_bib16","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.surg.2022.08.036","article-title":"Continuous manual agitation significantly improves temperature distribution during closed hyperthermic intraperitoneal chemotherapy: results of a porcine model","volume":"173","author":"Mouw","year":"2023","journal-title":"Surgery"},{"key":"10.1016\/j.asjsur.2024.10.155_bib17","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1002\/jso.23776","article-title":"Higher flow rates improve heating during hyperthermic intraperitoneal chemoperfusion","volume":"110","author":"Furman","year":"2014","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.asjsur.2024.10.155_bib18","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s13193-016-0498-0","article-title":"Hyperthermic intraperitoneal chemotherapy (HIPEC) methodology, drugs and bidirectional chemotherapy","volume":"7","author":"Valle","year":"2016","journal-title":"Indian J Surg Oncol"},{"key":"10.1016\/j.asjsur.2024.10.155_bib19","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.ejso.2014.03.013","article-title":"Contamination risk for operators performing semi-closed HIPEC procedure using cisplatin","volume":"40","author":"Caneparo","year":"2014","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.asjsur.2024.10.155_bib20","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.suronc.2016.06.001","article-title":"Operating personnel safety during the administration of hyperthermic intraperitoneal chemotherapy (HIPEC)","volume":"25","author":"Kyriazanos","year":"2016","journal-title":"Surg Oncol"},{"key":"10.1016\/j.asjsur.2024.10.155_bib21","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/jso.24248","article-title":"What made hyperthermic intraperitoneal chemotherapy an effective curative treatment for peritoneal surface malignancy: a 25-year experience with 1,125 procedures","volume":"113","author":"Passot","year":"2016","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.asjsur.2024.10.155_bib22","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.ejso.2015.09.005","article-title":"Cytoreductive surgery with a hyperthermic intraperitoneal chemotherapy program: safe after 40 cases, but only controlled after 140 cases","volume":"41","author":"Voron","year":"2015","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.asjsur.2024.10.155_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11010078","article-title":"Variation in clinical application of hyperthermic intraperitoneal chemotherapy: a review","volume":"11","author":"Helderman","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.asjsur.2024.10.155_bib24","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/annonc\/mdf019","article-title":"Heated intra-operative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetics and tissue distribution","volume":"13","author":"Elias","year":"2002","journal-title":"Ann Oncol"},{"key":"10.1016\/j.asjsur.2024.10.155_bib25","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1634\/theoncologist.10-2-112","article-title":"Update on chemotherapeutic agents utilized for perioperative intraperitoneal chemotherapy","volume":"10","author":"Sugarbaker","year":"2005","journal-title":"Oncologist"},{"key":"10.1016\/j.asjsur.2024.10.155_bib26","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1245\/s10434-010-0937-z","article-title":"Which method to deliver hyperthermic intraperitoneal chemotherapy with oxaliplatin? An experimental comparison of open and closed techniques","volume":"17","author":"Ortega-Deballon","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.asjsur.2024.10.155_bib27","first-page":"431","article-title":"Research on the best chemohyperthermia technique of treatment of peritoneal carcinomatosis after complete resection","volume":"1","author":"Elias","year":"2000","journal-title":"Int J Surg Investig"},{"key":"10.1016\/j.asjsur.2024.10.155_bib28","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/jso.21061","article-title":"Hyperthermic intraperitoneal chemotherapy: nomenclature and modalities of perfusion","volume":"98","author":"Glehen","year":"2008","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.asjsur.2024.10.155_bib29","first-page":"45","article-title":"Chemotherapy for intraperitoneal use: a review of hyperthermic intraperitoneal chemotherapy and early post-operative intraperitoneal chemotherapy","volume":"7","author":"Goodman","year":"2016","journal-title":"J\u00a0Gastrointest Oncol"},{"key":"10.1016\/j.asjsur.2024.10.155_bib30","first-page":"1328","article-title":"Prophylactic hyperthermic intraperitoneal chemotherapy (HIPEC) for the prevention and control of peritoneal metastasis in patients with gastrointestinal malignancies: a systematic review of randomized controlled trials","volume":"20","author":"Dominic","year":"2021","journal-title":"EXCLI J"},{"key":"10.1016\/j.asjsur.2024.10.155_bib31","article-title":"The role of prophylactic and adjuvant hyperthermic intraperitoneal chemotherapy (HIPEC) in prevention of peritoneal metastases in advanced colorectal cancer","volume":"12","author":"Sun","year":"2023","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.asjsur.2024.10.155_bib32","article-title":"Single versus multiple hyperthermic intraperitoneal chemotherapy applications for T4 gastric cancer patients: efficacy and safety profiles","volume":"13","author":"Zhang","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.asjsur.2024.10.155_bib33","doi-asserted-by":"crossref","first-page":"488","DOI":"10.3109\/02656736.2016.1152515","article-title":"Intraperitoneal chemotherapy hyperthermia (HIPEC) for peritoneal carcinomatosis of ovarian cancer origin by fluid and CO2 recirculation using the closed abdomen technique (PRS-1.0 Combat): a clinical pilot study","volume":"32","author":"S\u00e1nchez-Garc\u00eda","year":"2016","journal-title":"Int J Hyperthermia"},{"key":"10.1016\/j.asjsur.2024.10.155_bib34","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.surg.2013.12.005","article-title":"Experimental development of an intra-abdominal chemohyperthermia model using a closed abdomen technique and a PRS-1.0 Combat CO2 recirculation system","volume":"155","author":"S\u00e1nchez-Garc\u00eda","year":"2014","journal-title":"Surgery"},{"key":"10.1016\/j.asjsur.2024.10.155_bib35","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s13304-018-0557-x","article-title":"A\u00a0novel HIPEC technique using hybrid CO(2) recirculation system: intra-abdominal diffusion test in a porcine model","volume":"70","author":"Cianci","year":"2018","journal-title":"Updates Surg"},{"key":"10.1016\/j.asjsur.2024.10.155_bib36","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/01.sla.0000218089.61635.5f","article-title":"High intra-abdominal pressure enhances the penetration and antitumor effect of intraperitoneal cisplatin on experimental peritoneal carcinomatosis","volume":"244","author":"Esquis","year":"2006","journal-title":"Ann Surg"},{"key":"10.1016\/j.asjsur.2024.10.155_bib37","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.mehy.2015.07.001","article-title":"Pressurized intraperitoneal aerosol chemotherapy as an innovative approach to treat peritoneal carcinomatosis","volume":"85","author":"Tempfer","year":"2015","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.asjsur.2024.10.155_bib38","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1007\/s00464-012-2148-0","article-title":"Description of a novel approach for intraperitoneal drug delivery and the related device","volume":"26","author":"Sola\u00df","year":"2012","journal-title":"Surg Endosc"},{"key":"10.1016\/j.asjsur.2024.10.155_bib39","doi-asserted-by":"crossref","first-page":"e368","DOI":"10.1016\/S1470-2045(19)30318-3","article-title":"Pressurised intraperitoneal aerosol chemotherapy: rationale, evidence, and potential indications","volume":"20","author":"Alyami","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.asjsur.2024.10.155_bib40","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1245\/s10434-012-2360-0","article-title":"Laparoscopic hyperthermic intraperitoneal chemotherapy: indications, aims, and results: a systematic review of the literature","volume":"19","author":"Facchiano","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.asjsur.2024.10.155_bib41","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S1055-3207(03)00035-8","article-title":"Effective therapy for peritoneal dissemination in gastric cancer","volume":"12","author":"Yonemura","year":"2003","journal-title":"Surg Oncol Clin N Am"},{"key":"10.1016\/j.asjsur.2024.10.155_bib42","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1053\/ctrv.2001.0232","article-title":"Rationale and techniques of intra-operative hyperthermic intraperitoneal chemotherapy","volume":"27","author":"Witkamp","year":"2001","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.asjsur.2024.10.155_bib43","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/978-1-4613-1247-5_5","article-title":"Patterns of spread of recurrent intraabdominal sarcoma","volume":"82","author":"Sugarbaker","year":"1996","journal-title":"Cancer Treat Res"},{"key":"10.1016\/j.asjsur.2024.10.155_bib44","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1053\/ejso.2000.1038","article-title":"Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome","volume":"27","author":"Sugarbaker","year":"2001","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.asjsur.2024.10.155_bib45","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/path.3000","article-title":"Anoikis: an emerging hallmark in health and diseases","volume":"226","author":"Taddei","year":"2012","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.asjsur.2024.10.155_bib46","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/PPO.0b013e3181a58e74","article-title":"Technology of hyperthermic intraperitoneal chemotherapy in the United States, Europe, China, Japan, and Korea","volume":"15","author":"Esquivel","year":"2009","journal-title":"Cancer J"},{"key":"10.1016\/j.asjsur.2024.10.155_bib47","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1245\/s10434-007-9635-x","article-title":"Closed hyperthermic intraperitoneal chemotherapy with open abdomen: a novel technique to reduce exposure of the surgical team to chemotherapy drugs","volume":"15","author":"Benoit","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.asjsur.2024.10.155_bib48","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/jso.20370","article-title":"An instrument to provide containment of intraoperative intraperitoneal chemotherapy with optimized distribution","volume":"92","author":"Sugarbaker","year":"2005","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.asjsur.2024.10.155_bib49","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/1097-0142(19900101)65:1<65::AID-CNCR2820650115>3.0.CO;2-L","article-title":"Continuous hyperthermic peritoneal perfusion for the treatment of peritoneal dissemination in gastric cancers and subsequent second-look operation","volume":"65","author":"Fujimura","year":"1990","journal-title":"Cancer"},{"key":"10.1016\/j.asjsur.2024.10.155_bib50","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/981245","article-title":"Laparoscopic cytoreductive surgery and HIPEC in patients with limited pseudomyxoma peritonei of appendiceal origin","author":"Esquivel","year":"2012","journal-title":"Gastroenterol Res Pract"},{"key":"10.1016\/j.asjsur.2024.10.155_bib51","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ejso.2010.10.014","article-title":"Prognostic factors and oncologic outcome in 146 patients with colorectal peritoneal carcinomatosis treated with cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy: Italian multicenter study S.I.T.I.L.O","volume":"37","author":"Cavaliere","year":"2011","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.asjsur.2024.10.155_bib52","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12957-017-1119-2","article-title":"Are there intra-operative hemodynamic differences between the Coliseum and closed HIPEC techniques in the treatment of peritoneal metastasis? A retrospective cohort study","volume":"15","author":"Rodr\u00edguez Silva","year":"2017","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.asjsur.2024.10.155_bib53","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1200\/JCO.2003.04.187","article-title":"Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer","volume":"21","author":"Verwaal","year":"2003","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.asjsur.2024.10.155_bib54","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1245\/ASO.2004.05.009","article-title":"Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy with mitomycin C for peritoneal carcinomatosis from nonappendiceal colorectal carcinoma","volume":"11","author":"Shen","year":"2004","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.asjsur.2024.10.155_bib55","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/bjs.4473","article-title":"Intraperitoneal chemohyperthermia and attempted cytoreductive surgery in patients with peritoneal carcinomatosis of colorectal origin","volume":"91","author":"Glehen","year":"2004","journal-title":"Br J Surg"},{"key":"10.1016\/j.asjsur.2024.10.155_bib56","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1245\/s10434-007-9718-8","article-title":"Phase I trial of pegylated liposomal doxorubicin with hyperthermic intraperitoneal chemotherapy in patients undergoing cytoreduction for advanced intra-abdominal malignancy","volume":"15","author":"Harrison","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.asjsur.2024.10.155_bib57","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1477-7819-2-21","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from ovarian cancer","volume":"2","author":"Piso","year":"2004","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.asjsur.2024.10.155_bib58","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ejso.2011.10.009","article-title":"Low surface contamination by cis\/oxaliplatin during hyperthermic intraperitoneal chemotherapy (HIPEC)","volume":"38","author":"Schierl","year":"2012","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.asjsur.2024.10.155_bib59","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1158\/1055-9965.EPI-06-1069","article-title":"Non-Hodgkin lymphoma secondary to cancer chemotherapy","volume":"16","author":"Krishnan","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.asjsur.2024.10.155_bib60","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1093\/annonc\/mdi251","article-title":"Secondary leukemia after epirubicin-based adjuvant chemotherapy in operable breast cancer patients: 16 years experience of the French Adjuvant Study Group","volume":"16","author":"Campone","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1016\/j.asjsur.2024.10.155_bib61","first-page":"855","article-title":"Leukaemia and reproductive outcome among nurses handling antineoplastic drugs","volume":"49","author":"Skov","year":"1992","journal-title":"Br J Ind Med"},{"key":"10.1016\/j.asjsur.2024.10.155_bib62","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1472-6955-9-15","article-title":"Cancer incidence and adverse pregnancy outcome in registered nurses potentially exposed to antineoplastic drugs","volume":"9","author":"Ratner","year":"2010","journal-title":"BMC Nurs"},{"key":"10.1016\/j.asjsur.2024.10.155_bib63","first-page":"1","article-title":"Overall evaluations of carcinogenicity: an updating of IARC Monographs volumes 1 to 42","volume":"7","year":"1987","journal-title":"IARC Monogr Eval Carcinog Risks Hum Suppl"},{"key":"10.1016\/j.asjsur.2024.10.155_bib64","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.ejso.2006.05.011","article-title":"Investigations on safety of hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) with Mitomycin C","volume":"32","author":"Schmid","year":"2006","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.asjsur.2024.10.155_bib65","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/BF02557372","article-title":"Safety monitoring of the coliseum technique for heated intraoperative intraperitoneal chemotherapy with mitomycin C","volume":"9","author":"Stuart","year":"2002","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.asjsur.2024.10.155_bib66","doi-asserted-by":"crossref","first-page":"28","DOI":"10.2486\/indhealth.2014-0025","article-title":"Evaluation of oxaliplatin exposure of healthcare workers during heated intraperitoneal perioperative chemotherapy (HIPEC)","volume":"53","author":"Villa","year":"2015","journal-title":"Ind Health"},{"key":"10.1016\/j.asjsur.2024.10.155_bib67","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.toxlet.2018.05.031","article-title":"Occupational exposure to platinum drugs during intraperitoneal chemotherapy. Biomonitoring and surface contamination","volume":"298","author":"Ndaw","year":"2018","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.asjsur.2024.10.155_bib68","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.ejso.2015.07.012","article-title":"Professional risks when carrying out cytoreductive surgery for peritoneal malignancy with hyperthermic intraperitoneal chemotherapy (HIPEC): a French multicentric survey","volume":"41","author":"Ferron","year":"2015","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.asjsur.2024.10.155_bib69","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.13940","article-title":"Evaluation of cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for stage III epithelial ovarian cancer","volume":"3","author":"Lei","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.asjsur.2024.10.155_bib70","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/S1470-2045(23)00396-0","article-title":"Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian cancer (OVHIPEC-1): final survival analysis of a randomised, controlled, phase 3 trial","volume":"24","author":"Aronson","year":"2023","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.asjsur.2024.10.155_bib71","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJMoa1708618","article-title":"Hyperthermic intraperitoneal chemotherapy in ovarian cancer","volume":"378","author":"van Driel","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.asjsur.2024.10.155_bib72","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1200\/JCO.21.00605","article-title":"Secondary cytoreduction and carboplatin hyperthermic intraperitoneal chemotherapy for platinum-sensitive recurrent ovarian cancer: an MSK team ovary phase II study","volume":"39","author":"Zivanovic","year":"2021","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.asjsur.2024.10.155_bib73","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1245\/s10434-011-1631-5","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial","volume":"18","author":"Yang","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.asjsur.2024.10.155_bib74","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/jso.23633","article-title":"Impact of maximal cytoreductive surgery plus regional heated intraperitoneal chemotherapy (HIPEC) on outcome of patients with peritoneal carcinomatosis of gastric origin: results of the GYMSSA trial","volume":"110","author":"Rudloff","year":"2014","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.asjsur.2024.10.155_bib75","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/bjs.4695","article-title":"Treatment of peritoneal dissemination from gastric cancer by peritonectomy and chemohyperthermic peritoneal perfusion","volume":"92","author":"Yonemura","year":"2005","journal-title":"Br J Surg"},{"key":"10.1016\/j.asjsur.2024.10.155_bib76","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1001\/archsurg.139.1.20","article-title":"Cytoreductive surgery and intraperitoneal chemohyperthermia for peritoneal carcinomatosis arising from gastric cancer","volume":"139","author":"Glehen","year":"2004","journal-title":"Arch Surg"},{"key":"10.1016\/j.asjsur.2024.10.155_bib77","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1245\/s10434-020-08739-5","article-title":"A\u00a0phase II trial of cytoreduction, gastrectomy, and hyperthermic intraperitoneal perfusion with chemotherapy for patients with gastric cancer and carcinomatosis or positive cytology","volume":"28","author":"Badgwell","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.asjsur.2024.10.155_bib78","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1007\/s00423-022-02594-6","article-title":"Ten-year single-center experience with treatment of primary diffuse malignant peritoneal mesothelioma (DMPM) by cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)","volume":"407","author":"Acs","year":"2022","journal-title":"Langenbeck's Arch Surg"},{"key":"10.1016\/j.asjsur.2024.10.155_bib79","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1002\/ijc.34124","article-title":"Effect of HIPEC according to HRD\/BRCAwt genomic profile in stage III ovarian cancer: results from the phase III OVHIPEC trial","volume":"151","author":"Koole","year":"2022","journal-title":"Int J Cancer"},{"key":"10.1016\/j.asjsur.2024.10.155_bib80","article-title":"Hyperthermic intraperitoneal chemotherapy (HIPEC) after primary debulking surgery in advanced epithelial ovarian cancer: is BRCA mutational status making the difference?","volume":"31","author":"Ghirardi","year":"2022","journal-title":"Cancer Treat Res Commun"},{"key":"10.1016\/j.asjsur.2024.10.155_bib81","article-title":"Hyperthermic intraperitoneal chemotherapy-induced molecular changes in humans validate preclinical data in ovarian cancer","volume":"6","author":"Dellinger","year":"2022","journal-title":"JCO Precis Oncol"}],"container-title":["Asian Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1015958424024886?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1015958424024886?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T17:16:47Z","timestamp":1741799807000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1015958424024886"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":81,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S1015958424024886"],"URL":"https:\/\/doi.org\/10.1016\/j.asjsur.2024.10.155","relation":{},"ISSN":["1015-9584"],"issn-type":[{"value":"1015-9584","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyperthermic intraperitoneal chemotherapy: Ideal and reality","name":"articletitle","label":"Article Title"},{"value":"Asian Journal of Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.asjsur.2024.10.155","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Asian Surgical Association and Taiwan Society of Coloproctology. Publishing services by Elsevier B.V\u00e9","name":"copyright","label":"Copyright"}]}}